Manufacturer of Controlled Substances; Notice of Application; American Radiolabeled Chemicals, Inc.

---
identifier: "/us/fr/2012-12251"
source: "fr"
legal_status: "authoritative_unofficial"
title: "Manufacturer of Controlled Substances; Notice of Application; American Radiolabeled Chemicals, Inc."
title_number: 0
title_name: "Federal Register"
section_number: "2012-12251"
section_name: "Manufacturer of Controlled Substances; Notice of Application; American Radiolabeled Chemicals, Inc."
positive_law: false
currency: "2012-05-21"
last_updated: "2012-05-21"
format_version: "1.1.0"
generator: "[email protected]"
agency: "Justice Department"
document_number: "2012-12251"
document_type: "notice"
publication_date: "2012-05-21"
agencies:
  - "Justice Department"
  - "Drug Enforcement Administration"
fr_citation: "77 FR 30027"
fr_volume: 77
---


#  Manufacturer of Controlled Substances; Notice of Application; American Radiolabeled Chemicals, Inc.

Pursuant to § 1301.33(a), Title 21 of the Code of Federal Regulations (CFR), this is notice that on March 15, 2012, American Radiolabeled Chemicals, Inc., 101 Arc Drive, St. Louis, Missouri 63146, made application by renewal to the Drug Enforcement Administration (DEA) to be registered as a bulk manufacturer of the following basic classes of controlled substances:

| Drug | Schedule |
| --- | --- |
| Gamma Hydroxybutyric Acid (2010) | I |
| Ibogaine (7260) | I |
| Lysergic acid diethylamide (7315) | I |
| Tetrahydrocannabinols (7370) | I |
| Dimethyltryptamine (7435) | I |
| 1-[1-(2-Thienyl)cyclohexyl]piperidine (7470) | I |
| Dihydromorphine (9145) | I |
| Normorphine (9313) | I |
| Heroin (9200) | I |
| Amphetamine (1100) | II |
| Methamphetamine (1105) | II |
| Amobarbital (2125) | II |
| Phencyclidine (7471) | II |
| Phenylacetone (8501) | II |
| Cocaine (9041) | II |
| Codeine (9050) | II |
| Dihydrocodeine (9120) | II |
| Oxycodone (9143) | II |
| Hydromorphone (9150) | II |
| Ecgonine (9180) | II |
| Hydrocodone (9193) | II |
| Meperidine (9230) | II |
| Metazocine (9240) | II |
| Dextropropoxyphene, bulk (non-dosage forms) (9273) | II |
| Morphine (9300) | II |
| Oripavine (9330) | II |
| Thebaine (9333) | II |
| Oxymorphone (9652) | II |
| Phenazocine (9715) | II |
| Carfentanil (9743) | II |
| Fentanyl (9801) | II |

The company plans to manufacture small quantities of the listed controlled substances as radiolabeled compounds for biochemical research.

Any other such applicant, and any person who is presently registered with DEA to manufacture such substances, may file comments or objections to the issuance of the proposed registration pursuant to 21 CFR 1301.33(a).

Any such written comments or objections should be addressed, in quintuplicate, to the Drug Enforcement Administration, Office of Diversion Control, Federal Register Representative (ODL), 8701 Morrissette Drive, Springfield, Virginia 22152; and must be filed no later than July 20, 2012.

Dated: May 9, 2012.

Joseph T. Rannazzisi,

Deputy Assistant Administrator, Office of Diversion Control, Drug Enforcement Administration.